Karyopharm Therapeutics Inc. (NASDAQ:KPTI), a biopharmaceutical company with a market capitalization of $83.66 million and currently trading at $0.66 per share, held a Special Meeting of Stockholders ...

The company has secured contracts worth $1.7M for a recently acquired AI-powered advertising business in its portfolio.

Aclarion , Inc. (NASDAQ:ACON), a medical laboratory services provider with a current market capitalization of just $0.29 million, has announced a reverse stock split of its common stock at a ratio of ...

A 401(k) or 403(b) account, in contrast, is a defined-contribution plan because you determine the amount you (and perhaps your employer) contribute to it — by specifying that, say, 5% or 10% of your ...

ZK International Group Co., Ltd. (NASDAQ:ZKIN) is set to undergo a reverse stock split to potentially enhance its stock’s ...

Glucotrack (GCTK),announced that it will effect a 1-for-20 reverse stock split of its issued and outstanding common stock par value $0.001 per ...

February 4, 2025RUTHERFORD, N.J., Jan. 30, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: GCTK) (“Glucotrack” or the “Company”), a medical device company focused on the design, development, and commercialization ...

Introduction - Issuers listed on the Nasdaq Stock Market and the New York Stock Exchange (NYSE) often conduct reverse stock splits to ...

Inc. stock despite strong Phase 2b data. Click for my updated look at MNMD stock and its market opportunities.

ONTARIO, CA / ACCESS Newswire / January 29, 2025 / Focus Universal inc. (Nasdaq:FCUV) ("Focus" or the "Company"), a provider ...

ZK International Group (ZKIN) announces 1-for-7 reverse stock split to meet NASDAQ listing requirements, effective Jan.

Relmada Therapeutics, Inc. has recently received a notice from the Nasdaq Stock Market indicating that the company’s security did not maintain a minimum bid price of $1 per share for the 30 ...